Tidepool today announced a new data integration with Abbott for the company’s FreeStyle Libre continuous glucose monitors (CGMs).
The companies aim to deliver cloud-to-cloud integration for an automatic stream of data from patients using Abbott’s CGMs in the U.S. Data streams to Tidepool+, a diabetes data visualization and population health platform. Tidepool+ provides intuitive tracking and visualization of diabetes data to make the data informative and actionable for clinicians, people with diabetes and caregivers.
Along with its automated insulin delivery algorithms, Tidepool designs its cloud-to-cloud connections for simplicity and streamlined workflows. Clinics and health systems using Tidepool+ can initiate the connection with patients using FreeStyle libre 2 and 3 systems in a clinic or remotely.
Tidepool says its platform can seamlessly merge data from any sensor in the FreeStyle Libre portfolio into its population health dashboard and retrospective data displays. This creates a comprehensive overview for clinicians to assess outcomes for their entire patient population.
The new integration with Abbott could simplify data sharing by automating data upload to Tidepool for patients wearing the CGMs. According to a news release, it could create more efficient workflows for ongoing and proactive care.
“As a nonprofit organization, Tidepool is dedicated to providing better access to devices and data through interoperable solutions that give all people living with diabetes greater autonomy. We are excited to work with Abbott to empower healthcare providers and people living with diabetes to see data from their FreeStyle Libre sensors on Tidepool and Tidepool+,” said Brandon Arbiter, VP of business development and strategic partnerships at Tidepool.
